Skip to main content

Parkinsonism News (Page 3)

Combo Speech, Singing Therapy May Have Greater Effect in Parkinson Disease

FRIDAY, June 9, 2023 – Combining speech therapy with a singing intervention delivered via telerehabilitation seems to have a greater effect for patients with Parkinson disease (PD) with voice...

At Least 10 Pesticides Could Have Links to Parkinson's

FRIDAY, May 19, 2023 – Scientists say they've identified 10 pesticides that kill neurons involved in Parkinson's disease, marking a leap forward in their understanding of the movement disorder....

Allopurinol May Cut Risk for Neurodegenerative Diseases

FRIDAY, May 19, 2023 – Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE. Yizhe Song, from the...

New 'National Sports Brain Bank' Will Boost Head Injury Research

FRIDAY, May 19, 2023 – A new brain bank is accepting future donations from living athletes, in an effort to perform long-term research into the effects of sports-related concussion. The National...

Another Possible Exercise Bonus: Preventing Parkinson's

THURSDAY, May 18, 2023 – Regular exercise has a long list of health benefits, and a new study suggests another one could be added: a lower risk of Parkinson's disease. The study, of nearly 99,000...

Physical Activity Level Inversely Linked to Parkinson Disease in Women

THURSDAY, May 18, 2023 – In women, a higher physical activity (PA) level is associated with a lower incidence of Parkinson disease (PD), according to a study published online May 17 in Neurology....

Degreasing Chemical Trichloroethylene (TCE) Tied to Higher Odds for Parkinson's Disease

WEDNESDAY, May 17, 2023 – A chemical used to degrease industrial parts that was also used as a surgical anesthetic until the 1970s may increase the risk for Parkinson’s disease, researchers report. T...

Parkinson Disease Risk Increased With Exposure to Volatile Organic Compounds

TUESDAY, May 16, 2023 – Veterans exposed to volatile organic compounds (VOCs), including trichloroethylene (TCE), have an increased risk for Parkinson disease (PD), according to a study published...

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50...

FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease

March 21, 2017 – The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking l...

FDA Medwatch Alert: Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter

ISSUE: Nexus Pharmaceuticals Inc. is recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the presence of visible particulate matter in the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease

Related drug support groups

levodopa